Fig. 5From: Downregulation of lncRNA-PVT1 participates in the development of progressive chronic kidney disease among patients with congestive heart failureLPS treatment decreased PVT1 expression in cardiomyocytes. AC16 cells were treated with 0.1, 1, 2, and 5 μg/ml LPS for 24 h, followed by RNA isolations and RT-qPCRs to determine the expression of PVT1. * p < 0.05Back to article page